Portfolio Update

RNS Number : 1357T

Intl. Biotechnology Trust PLC

01 June 2009

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

Portfolio Update

The Board of International Biotechnology Trust plc (the 'Company') notes a follow on investment in the UK based unquoted portfolio company RespiVert.

On 1 June 2009, the Company invested £230k into RespiVert, which has reached the milestones necessary to trigger this second tranche of funding. RespiVert is a discovery company focused on chronic obstructive pulmonary disease and severe asthma, and this investment brings the total invested cost and current value in the company to £500k.

Enquiries:

Kate Bingham/David Pinniger

Telephone: [phone]       

SV Life Sciences Managers LLP   

Investment Manager                                        

Rachael Nelson

Telephone: [phone]

BNP Paribas Secretarial Services Limited

Company Secretary

1 June 2009

 

END

 

 

PFUBXGDLUSGGGCB